経皮ドラッグデリバリー力学

経皮HRT指標・市場

経皮的HRT製品評価・市場予測

経皮的ホルモン充填市場因子

地域的規制

臨床試験

品質・信頼性

処方ガイドライン・オフラベル処方の指標

マネージドケア・医療費支払者イニシアチブ

処方薬からOTCへの変更

市場予測

予測手法

予測：地域別

予測：薬剤クラス別

予測：デリバリーのフォームファクター別

市場シェアデータ

企業プロファイル

目次

Product Code: THR672V

Greystone Research Associates is pleased to announce the publication of a new
market study. Transdermal Hormone Replacement: Products, Players, Markets
and Forecasts is a comprehensive evaluation and analysis of the
technology, products and participants providing the driving force behind this
evolving segment of the healthcare sector.

The study is designed to provide drug company decision makers, drug
developers, device packaging designers, healthcare marketers, and supply chain
participants with a detailed understanding of the products, markets and
commercial opportunities for therapeutic hormones administered transdermally.
Provider organization business managers, healthcare administrators and
investors will also benefit from this study.

The Evolving Landscape for Hormone Replacement

As life expectancy in the developed world increases and populations age, the
incidence and associated morbidity of decreasing hormone levels have come to
the forefront as a quality-of-life issue for patients and their families. For
the past two decades, the healthcare industry has responded to this clinical
need by developing, testing and marketing hormone replacement therapy (HRT)
products. Because of their ease-of-use and dosing characteristics, drug
developers are continuing to turn to transdermal delivery systems for HRT
products. There are more than 40 million post-menopausal women in the United
States alone, and this group is expected to grow by 50% by 2020. With the
aging of the population worldwide, conditions and diseases such as menopause,
osteoporosis and heart disease, which may benefit from hormone replacement
therapy, are expected to become significantly more prevalent. The industry
continues to attract interest in the form of new participants and products.
While the global market continues to be dominated by the FDA-approved HRT
products of major pharmaceutical firms, regional markets are a bit more
competitive, and present unique challenges to transdermal HRT sector
participants.

Highlights

Analyzes and evaluates the global market opportunity for transdermal
hormone replacement and assesses the probable impact of evolving regulatory,
economic and demand factors

Assesses transdermal products approved or in development for the delivery
of therapeutic hormones

Methodology

Research methodology is based on primary research in the form of in-depth
interviews with key market participants, technology developers, distributors,
industry experts, and market influencers, a list that includes regulatory
officials, industry trade groups, and materials standards organizations.

Primary data is evaluated and normalized against secondary sources including
trade journal articles, technical literature, industry publications, company
data sheets and published information, and statistical data from government
agencies and trade associations.

Forecasts and projections of market demand and future market activity are
derived using standard modeling and statistical techniques.